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Infectious Complications After Small Bowel Transplantation in Adults 
S. Kusne, R. Manez. H. Bonet, K. Abu-Elmagd, H. Furukawa, W. Irish, A. Tzakis, S. Todo, and T.E. Starzl 
THE USE of FK 506 as an immunosuppressive agent at 
our institution allowed us to initiate a small bowel 
transplantation program. In this report. we describe the 
infectious complications that were encountered in the first 
21 adult patients following small bowel transplantation. 
METHODS 
Patient Population 
Between May I. 1990 and May I. 1993.21 adult patients under· 
went small bowel transplantation at the University of Pittsburgh. 
Patients were followed prospectively for infectious complications 
until October I. 1993 or until death. or for I month after the graft 
was lost. The median follow-up was 415 days (range 51 to 1156 
days). The female:male ratio was 10: II. and the mean age was 34 
years (range 21 to 58 years). There were ten patients who 
underwent small bowel transplantation only (SBTx). six also had 
liver transplantation (SBTxlU. and five had multi visceral trans-
plantation which included SBTxlL with other organs (MV). 
Immunosuppression 
The patients were given a continuous intravenous (IV) infusion of 
FK 506 at 0.15 mglkg per day and later orally at 0.15 mglkg every 
12 hours. Steroid induction included I g of methylprednisolone 
and steroid taper followed by maintenance of 20 mg prednisone. 
Treatment of acute rejection included methylprednisolone bolus 
and/or steroid taper. Steroid-resistant rejection was treated with 
OKT3 monoclonal antibody.· 
Prophylaxis and Infection Definitions 
We used our previous definitions of infectionsK~ Antimicrobial 
prophylaxis included: cefotaxime 4 gld IV together with ampicillin 
4 g/d IV for 3 days: ~ million Uld oral nystatin: amphotericin B IV 
10 to ~l mgtd; ganciclovir IV 10 mg/kg per day; and oral tri-
methoprimlsulfamethoxazole 80 mg and 400 mg every day. All 
patients were given oral colistin. gentamicin. and nystatin for 
selective bowel decontamination. 
RESULTS 
Twenty-one patients after small bowel transplantation 
were prospectively followed for infectious complications. 
Actuarial I-year patient survival was 84% ± 8.0%. The 
overall mortality was 33.3% (7 of 21). and six of seven 
(85.7lJt) deaths were associated with infection. There was 
a total of 91 infectious episodes (eps). shown in Table I. 
Four episodes were mixed. and were caused by bacteria 
and yeast together. Most of the infectious episodes oc-
curred more than 3 months after transplantation. The 
percentage of bacterial. viral. and fungal infections occur-
ring more than 3 months after transplantation were 55.5':'(. 
5:!.6t;c. and 85.70. respectively. 
All 21 patients had at least one episode of infection 
during the study period. When infectious episodes were 
Table 1. All 91 Infectious EplllOdH that Occurred In 21 Patients 
After Small Bowel Transplantation 
Type ot Infection 
Bacterial (n = 54) 
Une infection 
Wound infection 
Abdominal abscess 
Peritonitis 
Clostridium difficile colitis 
Pneumonia 
Bacteremia of unknown source 
Others 
Viral (n = 19) 
Symptomatic CMV 
Symptomatic E8V 
Fungal (n .. 14) 
Candida esophagitis 
Sinusitis 
Peritonitis 
Coccidioidomycosis 
Una infec:tion 
8actariaVFungai (n = 4) 
-' 
Number ot EpISOdes 
18 
6 
5 
6 
5 
4 
5 
5 
17 
2 
7 
2 
2 
1 
2 
subdivided in major categories. the following percentage of 
patients infected were observed: 81% (17 of 21) had 
bacterial infections: 76.2% (16 of 21) had viral infections: 
and 6 t .9% (13 of 21) had fungal infections. Although there 
was no statistical difference. MV transplantation patients 
had higher numbers of infectious episodes per patient. The 
median numbers of infectious episodes per patient were: 
3.0. 3.5. and 7.0 in the SBTx. SBTxlL. MV subpopula-
tions. respectively. 
There were 32 episodes of bacteremias and candidemias 
in 14 patients. with a median of 2.0 episodes per patient. 
The secondary sites of infection were: intravascular lines 
in 59.4% (19 of 32): abdomen in 12.5% (4 of 32); lung in 
6.3% (2 of 32) ; joint in 3.1% (I of 32); and in 18.8% (6 of 
32) a source was not identified. Overall. there were 41 
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isolates. of which 63.4% (26 of 41) were gram-positive 
bacteria. 24.4% (10 of 41) were gram-negative bacteria. 
2.4% (J of 41) were anaerobes. and 9.8% (4 of 41) were 
Candida species. 
DISCUSSION 
In this report. we describe the infectious complications 
that occurred in 21 consecutive patients who underwent 
small bowel transplantation. The rate of infection was very 
high and involved 100% of the popUlation studied. The 
high rate of infection was most likely caused by relatively 
high immunosuppression therapy, which was given to treat 
frequent rejection episodes. I The timing of infectious epi-
sodes was different from liver transplantation. where most 
of infections occur within the first 2 months after trans-
plantation. and where the rate of infectious complications 
is relatively low 3 months after transplantation.J Here 
instead. most infections occurred more than 3 months after 
transplantation. suggesting that patients were getting 
higher amounts of immunosuppression therapy. 
The most frequent infections were: bacteremias second-
ary to infected intravascular lines. Cytomegalovirus enter-
itis involving the transplanted bowel. and Candida esoph-
agitis. Recurrent CMV infection of the transplanted bowel 
is a unique problem to this popUlation and is described 
separately in this issue.4 Bacteremia was quite common in 
1683 
these patients and originated mostly from an infected 
central intravascular line or from the abdomen. Nineteen 
percent of bacteremias had no identified source. although 
we suspect most originated from the abdomen. It is possi-
ble that some of these bacteremias were related to bacte-
rial translocation from the transplanted bowel. though this 
was difficult to prove. Candida esophagitis was the most 
frequent fungal infection and occurred relatively late after 
transplantation and often occurred multiple times. This 
was usually associated with prolonged courses of antibi-
otic therapy in patients heavily colonized with yeast. 
Decrease in infectious complications is crucial in this 
population because of the high morbidity and high associ-
ation with mortality. This could be obtained by improve-
ment of antimicrobial prophylaxis on one side. and avoid-
ance of heavy immunosuppression on the other side. 
possibly by using new therapeutic modalities to control 
graft rejection. 
REFERENCES 
I. Abu-Elmagd K. Todo S. Tzakis A. et al: Transplant Proc 
(this issue) 
2. Kusne S. Dummer JS. Singh N. et al: Medicine 67: 132. 1988 
3. Alessiani M. Kusne S. Martin M. et al: Transplant Proc 
23:1501. 1991 -, 
4. Manez R, Kusne S. Abu-E1magd K. et al: Transplant Proc 
(this issue) 
